Kyverna Therapeutics, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2023 Dec2024
Revenue & cost
Revenue -0.19M-0.14M
Gross Profit -0.19M-0.14M
Operating items
Research & Development 49.92M112.47M
Selling, General & Administrative 12.48M30.13M
Operating Expenses 62.41M142.60M
Operating Income -62.41M-142.60M
EBIT -62.41M-142.60M
Non-operating items
Interest & Investment Income 2.28M15.36M
Other Non Operating Income -0.06M-0.09M
Non Operating Income 2.04M15.13M
Net income details
EBT -60.31M-127.39M
Profit After Tax -60.40M-127.50M
Income from Continuing Operations -60.31M-127.39M
Consolidated Net Income -60.31M-127.39M
Income towards Parent Company -60.31M-127.39M
Net Income towards Common Stockholders -60.31M-127.39M
Additional items
EPS (Basic) -0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 26.32M43.17M
EBITDA -62.41M-142.60M